Evidence map›Paper›PMID 36012970›Full record

ArticleJournal of clinical medicine2022

Airway Management of Patients with Suspected or Confirmed COVID-19: Survey Results from Physicians from 19 Countries in Latin America.

Manuel Granell, Nerea Sanchis, Carlos Delgado, Manuel Lozano, Marcio Pinho, Cecilia Sandoval, Carolina S Romero, Cesar Aldecoa, Juan P Cata, Jorge Neira and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Manuel GranellDepartment of Surgery (Anesthesiology), Faculty of Medicine, University of València, 46010 Valencia, Spain.ORCID 0000-0002-8350-3871
Nerea SanchisDepartment of Anesthesia, Critical Care and Pain Medicine, Consortium València General University Hospital of València, 46014 Valencia, Spain.
Carlos DelgadoDepartment of Anesthesia, Critical Care and Pain Medicine, Consortium València General University Hospital of València, 46014 Valencia, Spain.
Manuel LozanoFaculty of Pharmacy, University of València, 46010 Valencia, Spain.ORCID 0000-0003-2046-5959
Marcio PinhoDepartment of Anesthesia, Critical Care and Pain Medicine, Central Hospital of the Military Police of Rio de Janeiro, Rio de Janeiro 20221-270, Brazil.
Cecilia SandovalDepartment of Anesthesia, Critical Care and Pain Medicine, Hospital Angeles León, Leon 37150, Mexico.
Carolina S RomeroDepartment of Anesthesia, Critical Care and Pain Medicine, Consortium València General University Hospital of València, 46014 Valencia, Spain.ORCID 0000-0002-2325-4463
Cesar AldecoaDepartment of Anesthesia, Critical Care and Pain Medicine, University Hospital Río Hortega of Valladolid, 47012 Valladolid, Spain.ORCID 0000-0001-8789-5959
Juan P CataDepartment of Anesthesia, Critical Care and Pain Medicine, Anderson Cancer Center, Houston, TX 77030, USA.
Jorge NeiraTrauma Foundation Buenos Aires, Buenos Aires 1071, Argentina.
Jose De AndresDepartment of Surgery (Anesthesiology), Faculty of Medicine, University of València, 46010 Valencia, Spain.
Alejandro Herreros-PomaresResearch Foundation of the University General Hospital of València, 46014 Valencia, Spain.
Guillermo NavarroDepartment of Anesthesia, Critical Care and Pain Medicine, Emergency Hospital Dr. Clemente Alvarez, Rosario S2000, Argentina.
The Cov-Viaerea Network Study Group
Universitat de València · ESHospital General Universitario De Valencia · ESFavaloro Foundation · ARHospital Central da Polícia Militar · BRHospital de Emergencias Dr. Clemente Álvarez · ARHospital Universitario Río Hortega · ESThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Airway management during the COVID-19 pandemic has been one of the most challenging aspects of care that anesthesiologists and intensivists face. This study was conducted to evaluate the management of tracheal intubation in patients with suspected or confirmed COVID-19 infection. This is a cross-sectional and international multicenter study based on a 37-item questionnaire. The survey was available to physicians who had performed intubations and tracheostomies in patients with suspected or confirmed COVID-19 and had provided informed consent to participate. The primary outcome is the preference to use a specific device for tracheal intubation. Secondary outcomes are clinical practice variables, use of video laryngoscopes, difficult airway management, and safety features to prevent cross-infection. This study included 2411 physicians who performed an average of 11.90 and 20.67 tracheal intubations in patients diagnosed or suspected of having COVID-19 disease, respectively. Physicians were mainly from the specialties of Anesthesiology (61.2%) and Intensive Care (7.4%). COVID-19 infection diagnosed by positive PCR or serology in physicians participating in intubation in this study was 15.1%. Respondents considered preoxygenation for more than three minutes very useful (75.7%). The preferred device for tracheal intubation was the video laryngoscope (64.8%). However, the direct laryngoscope (57.9%) was the most commonly used, followed by the video laryngoscope (37.5%). The preferred device to facilitate intubation was the Eschmann guide (34.2%). Percutaneous tracheostomy was the preferred technique (39.5%) over the open tracheostomy (22%). The predicted or unpredicted difficult airway management in these patients was preferably performed with a video laryngoscope (61.7% or 63.7, respectively). Intubation was mostly performed by two or more expert airway physicians (61.6%). The use of personal protective equipment increased the practitioners' discomfort during intubation maneuvers. The video laryngoscope is the preferred device for intubating patients with COVID-19, combined with the Eschmann guide, flexible stylet within the endotracheal tube, or Frova guide to facilitate intubation. The sub-analysis of the two groups of physicians by the level of intubation experience showed a higher use of the video laryngoscope (63.4%) in the experts group and no significant differences between the two groups in terms of cross-infection rates in physicians, in their preference for the use of the video laryngoscope or in the number of intubations performed in confirmed or suspected COVID-19 patients.

Indexed as

airway devicesairway managementCOVID-19 patientscross-infectionLatin American countriestracheal intubationvideo laryngoscope

Identifiers

PMID36012970
PMCPMC9410431
OpenAlexW4291465149

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.